MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative Colitis

Two 8-week, randomized, placebo-controlled parent studies, SPD476-301 (by Lichtenstein and associates) and SPD476-302 (by Kamm and colleagues), of MMX Multi Matrix System (MMX) mesalamine have evaluated the induction of remission in ulcerative colitis patients, and a third study has evaluated the ma...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hanauer, Stephen B., Lichtenstein, Gary R., Kamm, Michael A., Sandborn, William J., Lees, Kirstin H., Barrett, Karen, Karlstadt, Robyn G., Diebold, Ron, Joseph, Raymond E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Millennium Medical Publishing 2009
Soggetti:
Feature
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886429/
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi